Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 631 of 1,261
  1. US 9662322

    Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  2. US 9662307

    Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof

    The Regents of the University of Colorado · Granted May 30, 2017 · Expires May 25, 2037

    granted
  3. US 9662316

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 30, 2017 · Expires May 25, 2037

    granted
  4. US 9662424

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted May 30, 2017 · Expires May 25, 2037

    granted
  5. US 9662306

    Compositions and methods for diagnosis and treatment of metabolic syndrome

    United States of America as represented by the Secretary of the Air Force · Granted May 30, 2017 · Expires May 25, 2037

    granted
  6. US 9662338

    Formulations of viloxazine

    Supernus Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  7. US 9662488

    Systems and methods for selectively migrating cells using electric fields

    The Regents of the University of California · Granted May 30, 2017 · Expires May 25, 2037

    granted
  8. EP 3169322

    DIÄTETISCHE ZUSAMMENSETZUNG MIT ANTIDYSLIPIDÄMISCHER AKTIVITÄT

    BERLIN-CHEMIE AG [DE] · Granted May 24, 2017 · Expires May 19, 2037

    granted
  9. US 9657096

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted
  10. US 9657269

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted
  11. US 9657090

    Method of treating alveolar bone loss through the use of anti-sclerostin antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 23, 2017 · Expires May 18, 2037

    granted
  12. US 9657012

    FAAH inhibitors

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  13. US 9656001

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted May 23, 2017 · Expires May 18, 2037

    granted
  14. US 9655909

    Personalized medicine for the prediction of therapy targeting the hedgehog pathway

    The Board of Regents of the University of Texas System · Granted May 23, 2017 · Expires May 18, 2037

    granted
  15. US 9655881

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 23, 2017 · Expires May 18, 2037

    granted
  16. US 9658230

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

    Ludwig-Maximilians-Universitat Munchen · Granted May 23, 2017 · Expires May 18, 2037

    granted
  17. US 9657292

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted
  18. US 9657288

    Connector compound peptide phage display

    BICYCLE THERAPEUTICS LIMITED · Granted May 23, 2017 · Expires May 18, 2037

    granted
  19. US 9657270

    Human disc tissue

    DiscGenics, Inc. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  20. US 9655352

    Humanized M-CSF mice

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  21. US 9657267

    Ex host maturation of germline stem cells

    PrimeGen Biotech LLC · Granted May 23, 2017 · Expires May 18, 2037

    granted
  22. US 9657102

    Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  23. US 9657099

    Anti-glucagon antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  24. US 9657066

    Pseudomonas exotoxin A with less immunogenic B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.